2m 2m 2m 2m 2m 2m 2m
ARCT THERAP HLDG (ARCT)
NASDAQ
$14.66-$0.07 (-0.45%)
Price as of Sep 11, 2026 7:45 PM EDT- $418.7MMarket Cap
- -14.95%1-Year Change
- BiotechnologyIndustry
ARCT THERAP HLDG (ARCT)
$14.66-$0.07 (-0.45%)
ARCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.73 | ||
Change | +$0.75 (+5.36%) | ||
Open | $14.06 | ||
High | $15.12 | ||
Low | $14.06 | ||
Previous Close | $13.98 | ||
Volume | 496,635 | ||
30-Day Average Volume | 1,454,964 | ||
1-Week Change | -6.89% | ||
1-Month Change | 95.88% | ||
1-Year Change | -14.95% | ||
3-Year Change | -53.28% | ||
5-Year Change | -72.34% | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $224.3M | ||
Market Cap | $418.7M | ||
Enterprise Value | $227.2M | ||
Period: QTR TTM FY | |||
Revenue | $880,000.00 | ||
Net Income | -$23.8M | ||
Free Cash Flow | -$19.9M | ||
EBIT | -$23.8M | ||
EBITDA | -$23.1M | ||
Net Working Capital | $163.6M | ||
EPS | -$0.84 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 258 | ||
P/B | 2 | ||
P/E | -18 | ||
PEG | -2 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue